The new device, called a Phenotype Analyzer Chip, was developed in the laboratory of ARC Laureate Professor Matt Trau and reads tiny biological particles in a patient’s bloodstream to get fast and accurate information on glioblastoma.

The research is published in Science Advances.

Dr. Lobb said glioblastoma was the most common form of brain cancer in Australia and is considered particularly deadly because of its delicate location, aggressive growth and limitations in accurate therapeutic monitoring.